Denis Cherednichenko

Graduated from the Ural State Law Academy, and holds a Master of Laws (LL.M.) degree from the University of Manchester (UK).

Before joining R-Pharm, he was head of the nuclear and radiation technologies for medicine and industry at Rosatom State Corporation. As the General Director of Rusatom Healthcare JSC, he was responsible for the development of projects in the field of radiation medicine, oncoradiology, creation of equipment and preparations for nuclear and radiation medicine in Russia and foreign countries.

Since 2019, he has been developing R-Pharm's product portfolio of diagnostic and therapeutic medical devices as Vice President of Medical Systems.